A phase II study of ribociclib in men with unresectable, incurable teratoma with recent progression Meeting Abstract


Authors: Castellano, D. E.; Quinn, D. I.; Feldman, D. R.; Fizazi, K.; del Muro, X. G.; Gietema, J. A.; Lauer, R. C.; Ising, M. E.; Aregay, M.; Crystal, A. S.; Vaughn, D. J.
Abstract Title: A phase II study of ribociclib in men with unresectable, incurable teratoma with recent progression
Meeting Title: 2019 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 7 Suppl.
Meeting Dates: 2019 Feb 14-16
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-03-01
Language: English
ACCESSION: WOS:000489108800521
DOI: 10.1200/JCO.2019.37.7_suppl.517
PROVIDER: wos
Notes: Meeting Abstract; 517 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Darren Richard Feldman
    340 Feldman